logo
logo
Sign in

Beta-lactam and Beta-lactamase Inhibitor Market, Growth, Demand and Technology Advancement Outlook in Healthcare Sector 2022-2030

avatar
Kanika Bath

At an estimated value of over 27.49 billion USD in 2019, the global Beta-lactam and Beta-lactamase Inhibitors Market is predicted to thrive at a CAGR of 1.9% and valued at over USD 34.20 billion over the forecast year 2020-2030. Beta-lactam inhibitors fall under a class of antibiotics that consists of all antibiotic agents that have a beta-lactam ring embedded in their molecular structure. These antibiotic agents help fight against bacterial infections and protozoa infections. The antibiotic agent either completely kills the bacteria or prevents it from growing and expanding. Names of some beta-lactam antibiotics are penicillin, cephalosporin and many others. On the other hand, beta-lactamase inhibitors are a class of drugs that block the activity of beta-lactamase enzymes and restricts the degradation of beta-lactam. Beta-lactamase enzymes are created either constitutively or on exposure to antimicrobials.

Market Segmentations and Scope of the Study:

The global beta-lactam and beta-lactamase inhibitors market share has been segmented on the basis of drug class, disease, route of administration and geography. On the basis of drug class, the market is categorized into Penicillin, Cephalosporin, Carbapanem, Monobactam and combination. Combination is sub segmented into Penicillin/Beta Lactamase inhibitors, Cephalosprin/Beta Lactamase inhibitors and Carbapanem/Beta inhibitors. On the basis of disease, the market is segmented into Urinary Tract Infection (excluding cUTI), Respiratory Infection, Skin Infection, Complicated Urinary Tract Infection (cUTI), Complicated Intra-Abdominal Infections (cIAI), Nosocomial Pneumonia, Blood Stream Infection and others. Nosocomial Pneumonia is sub segmented into Hospital Acquired Pneumonia, Ventilator Associated Pneumonia and other. Based on route of administration, the market is segmented into oral, intravenous and others. In terms of geography, the market is categorized into North America, Europe, Asia Pacific and RoW.

Request for a free sample- https://www.nextmsc.com/beta-lactam-beta-lactamase-inhibitors-market/request-sample

Geographical Analysis

The North America region is anticipated to hold the major market share as a result of advanced health care facilities and infrastructure in conjunction with rise in acceptance of beta-lactam and beta-lactamase inhibitors. The Asia Pacific region is predicted to show rapid and consistent growth in market share within the forecast period. This region also indicates increased prevalence of infectious diseases in addition to rise in consumption of such drugs, which also serves as favorable factor for the beta-lactam and beta-lactamase inhibitor market.

Inquire before buying- https://www.nextmsc.com/beta-lactam-beta-lactamase-inhibitors-market/inquire-before-buying

Competitive Landscape

Lucrative growth opportunities makes the Beta-lactam and Beta-lactamase inhibitors market extremely competitive. Some of the major players in the market include Abbott Laboratories, Allergan plc. F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc., Merck & Co. Inc. Mylan N.V., Novartis International AG, Pfizer Inc., Sanofi, Teva Pharmaceutical Industries and more. A number of developmental strategies have been adopted by companies in the recent years to further promote the growth of the market. For instance, in 2019 Cipla gained rights to novel and patented its anti-infective called Elores. Also, In July 2019, imipenem-cilastatin-relebactam was also approved by the FDA for treating cUTIs and cIAIs.

About Us:

Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics. We carefully analyse the historical data, augment it by constantly keeping an eye on the latest industry trends and estimate the future events to arrive at accurate market forecasts.

For more insights, please visit, https://www.nextmsc.com

collect
0
avatar
Kanika Bath
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more